📅Offer Date: 20 Feb 2026 – 24 Feb 2026
Data sourced from BSE & NSE · Last updated
Gaudium IVF and Women Health Limited IPO was subscribed 7.27x in total when bidding closed on 24 Feb 2026, with 1.62x in the QIB category, 14.05x in NII, 7.60x in retail. The issue ran from 20 Feb 2026 to 24 Feb 2026 at a price band of ₹75.00–₹79.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (7.60x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 41,77,240 | 67,67,129 | 1.62x |
| NIIs | 31,32,930 | 4,40,17,667 | 14.05x |
| SNIIs (<10L) | 10,44,310 | 1,74,71,306 | 16.73x |
| BNIIs (>10L) | 20,88,620 | 2,65,46,360 | 12.71x |
| Retail | 73,10,170 | 5,55,57,292 | 7.60x |
| Total | 1,46,20,340 | 10,62,89,872 | 7.27x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 33.00 | 53.46 | 1.62x |
| NIIs | 24.75 | 347.74 | 14.05x |
| Retail | 57.75 | 438.90 | 7.60x |
| Total | 115.50 | 840.10 | 7.27x |
Values derived from share count × issue price (₹79.00)
Because Gaudium IVF and Women Health Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.